<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01809730</url>
  </required_header>
  <id_info>
    <org_study_id>S12-02513</org_study_id>
    <nct_id>NCT01809730</nct_id>
  </id_info>
  <brief_title>Pilot Study: Cardiovascular Events in High Risk Orthopedic Surgical Patients</brief_title>
  <official_title>Pilot Study: Cardiovascular Events in High Risk Orthopedic Surgical Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a non-randomized, non-interventional pilot observational study designed to follow&#xD;
      high-risk patients through their surgical and hospital stay. The investigators will collect 2&#xD;
      4ml vial's of blood (total of 8ml) prior to surgery to assess CV biomarkers - inflammatory,&#xD;
      metabolic, hypercoagulable and platelet.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is primarily an observational pilot study. After identifying patients as high-risk&#xD;
      according to the following criteria: CAD and/or CVD and/or PAD and/or &gt;=60 years old and at&#xD;
      least 2 of the following - renal insufficiency, diabetes, COPD, hypertension, active smoker&#xD;
      (or active within 6 months of consent), cancer, congestive heart failure, or any blood clot -&#xD;
      they will be asked to sign a consent form. Patients surgical and hospital course will&#xD;
      continue as per standard of care. Prior to surgery, 8ml of blood will be collected for to&#xD;
      assess cardiovascular biomarkers including inflammatory, metabolic, hypercoagulable and&#xD;
      platelet biomarkers to be tested independently in Dr. Berger's lab in Smilow. Study staff&#xD;
      will perform electrocardiograms on POD 2. Results of these ECGs will not be placed in the&#xD;
      patients' charts. No other procedures will be done for research purposes only.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    no participants enrolled&#xD;
  </why_stopped>
  <start_date>May 2012</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiac ischemia/necrosis</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Venous thromboembolism</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Pulmonary embolism</measure>
    <time_frame>30 dyas</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Myocardial infarction</measure>
    <time_frame>30 Days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cerebral vascular event</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Death</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Transient ischemic attack</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Surgical site infection</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Delayed wound healing</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinically relevant bleeding</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Transfusion within 48 hours post-op</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">0</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Cerebral Vascular Disease</condition>
  <condition>Peripheral Artery Disease</condition>
  <condition>Renal Insufficiency</condition>
  <condition>Diabetes</condition>
  <condition>COPD</condition>
  <condition>Hypertension</condition>
  <condition>Active Smoker</condition>
  <condition>Cancer</condition>
  <condition>CHF</condition>
  <condition>Prior DVT/PE</condition>
  <arm_group>
    <arm_group_label>Cardiovascular risk</arm_group_label>
    <description>patients with CV disease</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      CV biomarkers - inflammatory, metabolic, hypercoagulable and platelet.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        This pilot, observational study is designed to identify and follow orthopedic surgical&#xD;
        patients meeting specific high-risk criteria for postoperative cardiovascular events. All&#xD;
        normal standard of care will be maintained. Patients will be observed from Pre-Admission&#xD;
        Testing (PAT) visit through hospital discharge.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  • ≥ 21 years of age&#xD;
&#xD;
               -  Subjects undergoing open orthopedic surgery of the hip, knee or spine&#xD;
&#xD;
               -  High-risk subject cohort:&#xD;
&#xD;
               -  Coronary artery disease (CAD), or&#xD;
&#xD;
               -  Cerebrovascular disease (CVD) (prior stroke, TIA or carotid artery disease (&gt;70%&#xD;
                  stenosis), or&#xD;
&#xD;
               -  Peripheral artery disease (PAD), or&#xD;
&#xD;
               -  Age ≥ 60 years and any 2 of the following:&#xD;
&#xD;
                    -  Renal insufficiency (creatinine clearance &lt; 60ml/min)&#xD;
&#xD;
                    -  Diabetes&#xD;
&#xD;
                    -  Chronic Obstructive Pulmonary Disease (COPD)&#xD;
&#xD;
                    -  Hypertension&#xD;
&#xD;
                    -  Active smoker or stopped less than 30 days prior to consent&#xD;
&#xD;
                    -  Cancer&#xD;
&#xD;
                    -  Congestive heart failure&#xD;
&#xD;
                    -  Prior blood clot&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  • Severe co-morbid condition with life expectancy &lt; 6 months&#xD;
&#xD;
               -  Inability to give informed consent or adhere to follow-up as per protocol&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>NYU Hospital for Joint Diseases</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <study_first_submitted>March 11, 2013</study_first_submitted>
  <study_first_submitted_qc>March 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 13, 2013</study_first_posted>
  <last_update_submitted>November 16, 2015</last_update_submitted>
  <last_update_submitted_qc>November 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 17, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

